Correlation Between Catalyst Pharmaceuticals and Acumen Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Catalyst Pharmaceuticals and Acumen Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Catalyst Pharmaceuticals and Acumen Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Catalyst Pharmaceuticals and Acumen Pharmaceuticals, you can compare the effects of market volatilities on Catalyst Pharmaceuticals and Acumen Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Catalyst Pharmaceuticals with a short position of Acumen Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Catalyst Pharmaceuticals and Acumen Pharmaceuticals.
Diversification Opportunities for Catalyst Pharmaceuticals and Acumen Pharmaceuticals
0.67 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Catalyst and Acumen is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Catalyst Pharmaceuticals and Acumen Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acumen Pharmaceuticals and Catalyst Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Catalyst Pharmaceuticals are associated (or correlated) with Acumen Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acumen Pharmaceuticals has no effect on the direction of Catalyst Pharmaceuticals i.e., Catalyst Pharmaceuticals and Acumen Pharmaceuticals go up and down completely randomly.
Pair Corralation between Catalyst Pharmaceuticals and Acumen Pharmaceuticals
Given the investment horizon of 90 days Catalyst Pharmaceuticals is expected to generate 0.47 times more return on investment than Acumen Pharmaceuticals. However, Catalyst Pharmaceuticals is 2.14 times less risky than Acumen Pharmaceuticals. It trades about 0.04 of its potential returns per unit of risk. Acumen Pharmaceuticals is currently generating about -0.01 per unit of risk. If you would invest 1,587 in Catalyst Pharmaceuticals on August 27, 2024 and sell it today you would earn a total of 561.00 from holding Catalyst Pharmaceuticals or generate 35.35% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Catalyst Pharmaceuticals vs. Acumen Pharmaceuticals
Performance |
| Timeline |
| Catalyst Pharmaceuticals |
| Acumen Pharmaceuticals |
Catalyst Pharmaceuticals and Acumen Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Catalyst Pharmaceuticals and Acumen Pharmaceuticals
The main advantage of trading using opposite Catalyst Pharmaceuticals and Acumen Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Catalyst Pharmaceuticals position performs unexpectedly, Acumen Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acumen Pharmaceuticals will offset losses from the drop in Acumen Pharmaceuticals' long position.| Catalyst Pharmaceuticals vs. Eliem Therapeutics | Catalyst Pharmaceuticals vs. HCW Biologics | Catalyst Pharmaceuticals vs. Scpharmaceuticals | Catalyst Pharmaceuticals vs. Milestone Pharmaceuticals |
| Acumen Pharmaceuticals vs. Terns Pharmaceuticals | Acumen Pharmaceuticals vs. X4 Pharmaceuticals | Acumen Pharmaceuticals vs. Day One Biopharmaceuticals | Acumen Pharmaceuticals vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |